A novel binding site for retigabine on KCNQ5

Details for Australian Patent Application No. 2007207596 (hide)

Owner Wyeth

Inventors Wang, Qiang; Argentieri, Thomas Michael; Liu, Kun

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2007207596

PCT Pub. Number WO2007/084531

Priority 60/760,252 19.01.06 US

Filing date 17 January 2007

Wipo publication date 26 July 2007

International Classifications

C07K 14/43 (2006.01) Peptides having more than 20 amino acids

C07K 14/435 (2006.01) Peptides having more than 20 amino acids - from animals

Event Publications

5 June 2008 PCT application entered the National Phase

  PCT publication WO2007/084531 Priority application(s): WO2007/084531

27 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007207600-Neuronal nicotinic receptor ligands and their use

2007207591-Package for containers